Log In
Print
BCIQ
Print
Print this Print this
 

Tafinlar, dabrafenib (GSK2118436)

Also known as: 2118436

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral BRAF protein kinase inhibitor
Molecular Target BRAF
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today